ArticleInternational journal of cancer2022
The impact of the COVID-19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020.
Article in International journal of cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Epidemiology of Incidence and Mortality Due to Head and Neck Cancer in Poland in 2000 to 2022.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- Cancer Diagnoses and Deaths in Hungary, 2011-2023: Nationwide Trends Before, During, and After the COVID-19 Pandemic.Cancers · 2026Article
- Changes in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population-based cohort study.International journal of cancer · 2026Article
- International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.The Lancet. Oncology · 2026Article
- COVID-19 and Lung Cancer Interactions: A Literature Review.Medical sciences (Basel, Switzerland) · 2025Review
- Impact of the COVID-19 pandemic on the quality of life of early breast cancer patients undergoing adjuvant chemotherapy - an observational, multicenter study.Acta oncologica (Stockholm, Sweden) · 2025Observational
- Exploring health system resilience during the COVID-19 pandemic in Sweden: an interrupted time series analysis of service utilisation and sociodemographic differences.BMC health services research · 2025Article
- Alcohol consumption and breast lesions: targets for risk-based screening in high-risk Italian women.Breast cancer (Tokyo, Japan) · 2025Article
- The COVID-19 pandemic increased the incidence of newly diagnosed cancers: evidence from a large cohort study in Southern Italy.BMC medicine · 2025Article
- The long-lasting impacts of the COVID-19 pandemic on population-based cancer survival: what are the implications for data analysis?British journal of cancer · 2025Review
- Article
- Changes in cancer incidence and stage during the COVID-19 pandemic in 2020-2021 in the Nordic countries.Acta oncologica (Stockholm, Sweden) · 2025Article
- COVID-19 pandemic impact on gynecologic cancer treatment pathways in a Finnish tertiary center.Acta obstetricia et gynecologica Scandinavica · 2024Article
- Impact of the COVID-19 pandemic on cancer diagnoses, oncological care and cancer patients in Germany: a report from the "COVID & Cancer" workshop 2023 of the German Society for Epidemiology (DGEpi).Journal of cancer research and clinical oncology · 2024Article
- The impact of COVID-19 on private healthcare service utilisation: time series analysis in the capital region of Finland during 2020-2022.BMC public health · 2024Article
- Impact of COVID-19 pandemic on bone and soft tissue sarcoma patients' consultation and diagnosis.Scientific reports · 2024Article
- Unveiling the Effects of the COVID-19 Pandemic on Lung Cancer Surgery.Medicina (Kaunas, Lithuania) · 2024Article
- The impact of COVID-19 on healthcare booking and cancellation patterns: time series analysis of private healthcare service utilisation in Finland.BMC health services research · 2024Article
- Real-World Evidence of the Impact of the COVID-19 Pandemic on Lung Cancer Survival: Canadian Perspective.Current oncology (Toronto, Ont.) · 2024Article
- The impact of the COVID-19 pandemic on incidence gap in screen-detectable cancers: a cohort study in Greater Poland, Poland.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The severity of the COVID-19 pandemic and subsequent mitigation strategies have varied across the Nordic countries. In a joint Nordic population-based effort, we compared patterns of new cancer cases and notifications between the Nordic countries during 2020. We used pathology notifications to cancer registries in Denmark, the Faroe Islands, Finland, Iceland, Norway and Sweden to determine monthly numbers of pathology notifications of malignant and in situ tumours from January to December 2020 compared to 2019 (2017-2019 for Iceland and the Faroe Islands). We compared new cancer cases per month based on unique individuals with pathology notifications. In April and May 2020, the numbers of new malignant cases declined in all Nordic countries, except the Faroe Islands, compared to previous year(s). The largest reduction was observed in Sweden (May: -31.2%, 95% CI -33.9, -28.3), followed by significant declines in Finland, Denmark and Norway, and a nonsignificant decline in Iceland. In Denmark, Norway, Sweden and Finland the reporting rates during the second half of 2020 rose to almost the same level as in 2019. However, in Sweden and Finland, the increase did not compensate for the spring decline (annual reduction -6.2% and -3.6%, respectively). Overall, similar patterns were observed for in situ tumours. The COVID-19 pandemic led to a decline in rates of new cancer cases in Sweden, Finland, Denmark and Norway, with the most pronounced reduction in Sweden. Possible explanations include the severity of the pandemic, temporary halting of screening activities and changes in healthcare seeking behaviour.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.